卓航控股(01865.HK)接獲清盤呈請 遭索償2,000萬元
卓航控股(01865.HK)公布,近期收到由呈請人勝冠貿易向香港高等法院原訟法庭提交的清盤呈請,申請根據公司(清盤及雜項條文)條例(香港法例第32章)的條文,對公司進行清盤。呈請定於5月11日於高等法院聆訊。
呈請與呈請人根據2021年4月16日的指稱貸款協議索賠指稱未償還債務2,000萬元有關。公司澄清指,並無訂立且並不知悉指稱貸款協議或產生任何債務,公司及其附屬公司銀行均無收取該債務款項,已向香港警方報告該案件,並將對債務的存在情況提出抗辯及針對呈請進行強有力辯護。
公司又指,已向法律顧問尋求意見,以維護公司權益及釐定有關呈請的下一步措施及可能採取的行動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.